(Q40756146)

23 September 2017

title

The American Cancer Society challenge goal to reduce US cancer mortality by 50% between 1990 and 2015: Results and reflections (English)

1 reference

23 September 2017

Tim Byers

1

1 reference

23 September 2017

Richard C Wender

2

1 reference

23 September 2017

Ahmedin Jemal

3

1 reference

23 September 2017

Arnold M Baskies

4

1 reference

23 September 2017

Elizabeth E Ward

5

1 reference

23 September 2017

Otis W Brawley

6

1 reference

23 September 2017

language of work or name

English

0 references

publication date

13 May 2016

1 reference

23 September 2017

1 reference

23 September 2017

volume

66

1 reference

23 September 2017

issue

5

1 reference

23 September 2017

page(s)

359-369

1 reference

Reconstructing PSA testing patterns between black and white men in the US from Medicare claims and the National Health Interview Survey.

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

The tobacco epidemic in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Master Settlement Agreement (MSA) spending and tobacco control efforts

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Reduced lung-cancer mortality with low-dose computed tomographic screening

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

American Cancer Society lung cancer screening guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Prevalence of childhood and adult obesity in the United States, 2011-2012

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Increase in screening for colorectal cancer in older Americans: results from a national survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Trends in colorectal cancer test use among vulnerable populations in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

The impact of a celebrity promotional campaign on the use of colon cancer screening: the Katie Couric effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

No one left behind: the road to 80% by 2018.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Where can colorectal cancer screening interventions have the most impact?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Effect of screening and adjuvant therapy on mortality from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Mammography rates 3 years after the 2009 US Preventive Services Task Force Guidelines changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Past, present, and future challenges in breast cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Biomarker assessment and molecular testing for prognostication in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Menopausal hormone therapy and breast cancer mortality: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

The decrease in breast-cancer incidence in 2003 in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Breast cancer statistics, 2015: Convergence of incidence rates between black and white women

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Health disparities in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Prostate-cancer mortality at 11 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

American Cancer Society guideline for the early detection of prostate cancer: update 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connection

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Long-term survival of participants in the prostate cancer prevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Aspirin, NSAIDs, and risk of prostate cancer: results from the REDUCE study

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Smoking and mortality--beyond established causes

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Does intentional weight loss reduce cancer risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Screening for Hepatitis C Virus Infection in Adults: U.S. Preventive Services Task Force Recommendation Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Universal screening for chronic hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Simple, Effective, but Out of Reach? Public Health Implications of HCV Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Prevention of human papillomavirus-associated cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Pancreatic cancer: overview of descriptive epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Childhood and adolescent cancer statistics, 2014.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Cancer statistics for Asian Americans, Native Hawaiians, and Pacific Islanders, 2016: Converging incidence in males and females

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Regional patterns and trends in cancer mortality among American Indians and Alaska Natives, 1990-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

The impact of socioeconomic status on survival after cancer in the United States : findings from the National Program of Cancer Registries Patterns of Care Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Association Between the Affordable Care Act Dependent Coverage Expansion and Cervical Cancer Stage and Treatment in Young Women

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Dependent coverage and use of preventive care under the Affordable Care Act.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Elimination of cost-sharing and receipt of screening for colorectal and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

The Sequence of the Human Genome

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Genomics of Cancer and a New Era for Cancer Prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Setting Goals for Cancer Mortality: Earlier Initiatives Offer Lessons for the Future

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

A midpoint assessment of the American Cancer Society challenge goal to halve the U.S. cancer mortality rates between the years 1990 and 2015.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

Effects of Misattribution in Assigning Cause of Death on Prostate Cancer Mortality Rates

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21348

21 January 2018

Identifiers

DOI

10.3322/CAAC.21348

1 reference

23 September 2017

1 reference